BAAM
NEO icon

Baker Avenue Asset Management’s NeoGenomics NEO Stock Holding History

Baker Avenue Asset Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-224
Closed -$2.75K – 1088
2023
Q3 		$2.75K Hold
224
– – ﹤0.01% 1068
2023
Q2 		$3.6K Hold
224
– – ﹤0.01% 897
2023
Q1 		$3.9K Hold
224
– – ﹤0.01% 893
2022
Q4 		$2.07K Buy
+224
New +$2.09K ﹤0.01% 937

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Baker Avenue Asset Management's NEO Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of NeoGenomics (NEO) in Q4 2023, closing a stake of 224 shares — an estimated $2.75K sold.

Baker Avenue Asset Management first reported a position in NEO in Q4 2022 and held it in 4 quarters. The position peaked at $3.9K in Q1 2023. 287 funds tracked by Wall St. Rank hold NEO as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining NeoGenomics position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 224 NeoGenomics shares in Q4 2023, an estimated $2.75K.
  • Baker Avenue Asset Management first reported a position in NeoGenomics in Q4 2022 and held it in 4 quarters.
  • Baker Avenue Asset Management's NeoGenomics position peaked at $3.9K in Q1 2023.
  • 287 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.